# Healthcare Companies Beat Q3 EPS Estimates at a 96% Rate

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/45535
Published: 2026-10-31T14:47:07.000Z
Updated: 2026-10-31T14:47:07.000Z
Section: Business

> Of 23 companies in the tally, 16 posted year-over-year earnings growth and 21 beat revenue estimates.

In the 23-company tally, 22 companies beat EPS estimates and 21 beat revenue estimates; all 23 posted year-over-year revenue growth.

Sixteen companies, or 70%, had higher earnings than a year earlier. Revenue beat estimates at 21 companies, or 91%, even as every company in the tally recorded year-over-year revenue growth.

Eli Lilly had the strongest revenue growth among the companies highlighted, at 39%, and raised its fiscal 2026 revenue outlook. Regeneron’s revenue increased 36%. AbbVie, Gilead, Biogen and Illumina also raised parts of their fiscal 2026 outlooks.

Amgen, Pfizer, Vertex Pharmaceuticals and Novo Nordisk are among the healthcare companies scheduled to report results next week.